Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
- PMID: 34578859
- PMCID: PMC8471956
- DOI: 10.3390/nu13092981
Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
Abstract
Osteoporosis is characterized by bone loss. The present study aims to investigate the effects of bovine colostrum (BC) on bone metabolism using ovariectomized (OVX) and orchidectomized (ORX) rat models. Twenty-seven-week-old Wistar Han rats were randomly assigned as: (1) placebo control, (2) BC supplementation dose 1 (BC1: 0.5 g/day/OVX, 1 g/day/ORX), (3) BC supplementation dose 2 (BC2: 1 g/day/OVX, 1.5 g/day/ORX) and (4) BC supplementation dose 3 (BC3: 1.5 g/day/OVX, 2 g/day/ORX). Bone microarchitecture, strength, gene expression of VEGFA, FGF2, RANKL, RANK and OPG, and bone resorption/formation markers were assessed after four months of BC supplementation. Compared to the placebo, OVX rats in the BC1 group exhibited significantly higher cortical bone mineral content and trabecular bone mineral content (p < 0.01), while OVX rats in the BC3 group showed significantly higher trabecular bone mineral content (p < 0.05). ORX rats receiving BC dose 2 demonstrated significantly higher levels of trabecular bone mineral content (p < 0.05). Serum osteocalcin in the ORX was pointedly higher in all BC supplementation groups than the placebo (BC1: p < 0.05; BC2, BC3: p < 0.001). Higher doses of BC induced significantly higher relative mRNA expression of OPG, VEGFA, FGF2 and RANKL (p < 0.05). BC supplementation improves bone metabolism of OVX and ORX rats, which might be associated with the activation of the VEGFA, FGF2 and RANKL/RANK/OPG pathways.
Keywords: bone; bovine colostrum; osteoporosis; supplementation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Pharmacological and Non-Pharmacological Agents versus Bovine Colostrum Supplementation for the Management of Bone Health Using an Osteoporosis-Induced Rat Model.Nutrients. 2022 Jul 11;14(14):2837. doi: 10.3390/nu14142837. Nutrients. 2022. PMID: 35889794 Free PMC article.
-
Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.Acta Pharmacol Sin. 2012 Oct;33(10):1277-84. doi: 10.1038/aps.2012.83. Epub 2012 Aug 20. Acta Pharmacol Sin. 2012. PMID: 22902986 Free PMC article.
-
Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats.Biol Trace Elem Res. 2018 Jun;183(2):288-295. doi: 10.1007/s12011-017-1134-8. Epub 2017 Aug 25. Biol Trace Elem Res. 2018. PMID: 28842860
-
[Animal models for bone and joint disease. Ovariectomized and orchidectomized animals].Clin Calcium. 2011 Feb;21(2):164-70. Clin Calcium. 2011. PMID: 21289412 Review. Japanese.
-
A Systematic Review of the Influence of Bovine Colostrum Supplementation on Leaky Gut Syndrome in Athletes: Diagnostic Biomarkers and Future Directions.Nutrients. 2022 Jun 17;14(12):2512. doi: 10.3390/nu14122512. Nutrients. 2022. PMID: 35745242 Free PMC article. Review.
Cited by
-
Pharmacological and Non-Pharmacological Agents versus Bovine Colostrum Supplementation for the Management of Bone Health Using an Osteoporosis-Induced Rat Model.Nutrients. 2022 Jul 11;14(14):2837. doi: 10.3390/nu14142837. Nutrients. 2022. PMID: 35889794 Free PMC article.
References
-
- Adachi J.D., Ioannidis G., Pickard L., Berger C., Prior J.C., Joseph L., Hanley D.A., Olszynski W.P., Murray T.M., Anastassiades T., et al. The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos) Osteoporos. Int. 2003;14:895–904. doi: 10.1007/s00198-003-1483-3. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical